All Posts: lung cancer

• Intensive Telephone-Based Cessation Counseling Results in Improved Smoking Quit Rates

  WASHINGTON (July 12, 2022) — Offering intensive, weekly telephone-based cessation counseling along with nicotine replacement for people who smoke and who were undergoing screening for lung cancer resulted in over a twofold greater cigarette quit rate compared to people who received minimal counseling and nicotine replacement, according to results of a national, randomized trial conducted […]

  Category: News Release Tags: lung cancer, smoking, smoking cessation

• Georgetown Lombardi Oncologists Encourage Patients to Keep Up with Cancer Screenings

  (November 20, 2020) — If you’re due for a routine cancer screening test, you should contact your doctor to find out if it can be safely deferred until the risk of COVID-19 goes down. In contrast, if you have symptoms that could be a sign of cancer, don’t delay and don’t let the pandemic discourage […]

  Category: Lombardi Stories Tags: breast cancer, cancer, cancer screening, gastrointestinal cancer, lung cancer, telemedicine

• FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research

  (September 14, 2020) — Julie Shanholtz was having an uneventful summer in 2017 working full time with the same employer she’d had for the past 30 years when she developed an “odd cough” that quickly became severe, but no other symptoms. “I had always been very active and healthy — and didn’t smoke,” the 54-year-old […]

  Category: Lombardi Stories Tags: cancer, cancer research, clinical trials, lung cancer, non-small cell lung cancer

• Adding Smoking Cessation to Lung Cancer Screening Can Reduce Mortality by 14%

  WASHINGTON (March 9, 2020) — Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study led by researchers at the University of Michigan and Georgetown Lombardi Comprehensive Cancer Center. The study is published […]

  Category: News Release Tags: cancer, lung cancer, smoking, smoking cessation

• Nearly One-Quarter of Completed Lung Cancer Clinical Trial Results Are Not Published

  WASHINGTON (November 6, 2019) — Despite the lengthy time and money commitments that are required to conduct clinical trials, a new analysis has found that up to one-fourth of completed lung cancer clinical trial results are not published, thereby depriving patients, the research community and the public of a complete picture of the current state of […]

  Category: News Release Tags: cancer, cancer research, clinical trials, lung cancer

• When Enough is Enough! Smoking Cessation at Georgetown Lombardi

  Two programs offered through Georgetown Lombardi and MedStar Georgetown University Hospital offer options to help smokers understand their risk for lung cancer and quit smoking, both before and after they’ve received a cancer diagnosis.

  Category: Lombardi Stories Tags: lung cancer, smoking cessation

• Rare but Important Gene Target Found in Many Tumor Types, Suggesting New Therapy Possible

  A consortium of researchers led by Georgetown Lombardi Comprehensive Cancer Center investigators have completed the largest analysis of a new gene fusion they believe is responsible for development of a wide spectrum of cancer types.

  Category: News Release Tags: cancer, lung cancer

• Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer

  The U.S. Food and Drug Administration’s approval of a drug used in combination with chemotherapy for the initial treatment of extensive-stage small cell lung cancer marks the end of numerous failed attempts to improve survival for those with the deadly disease.

  Category: Lombardi Stories Tags: cancer, lung cancer